Massachusetts Financial Services’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,829
Closed -$354K – 1074
2026
Q2
$354K Sell
10,829
-11,816
-52% -$379K ﹤0.01% 972
2026
Q1
$737K Buy
22,645
+3,544
+19% +$116K ﹤0.01% 864
2025
Q4
$606K Buy
+19,101
New +$574K ﹤0.01% 856

Other funds holding STOK

Massachusetts Financial Services's STOK Position: Q3 2026 in Review

Massachusetts Financial Services sold out of Stoke Therapeutics (STOK) in Q3 2026, closing a stake of 10,829 shares — an estimated $354K sold.

Massachusetts Financial Services first reported a position in STOK in Q4 2025 and held it in 3 quarters. The position peaked at $737K in Q1 2026. 185 funds tracked by Wall St. Rank hold STOK as of Q3 2026.

  • Massachusetts Financial Services reported no remaining Stoke Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Massachusetts Financial Services sold 10,829 Stoke Therapeutics shares in Q3 2026, an estimated $354K.
  • Massachusetts Financial Services first reported a position in Stoke Therapeutics in Q4 2025 and held it in 3 quarters.
  • Massachusetts Financial Services's Stoke Therapeutics position peaked at $737K in Q1 2026.
  • 185 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.

Based on Massachusetts Financial Services's 13F filing for Q3 2026, filed 12 Nov 2026.